CAPTEK^® Softgel International (“CAPTEK”), a portfolio company of Swander Pace Capital (“SPC”) and a North American contract manufacturer of softgel and gummy vitamins, minerals and supplements (“VMS”), today announced two key executive appointments as it continues to strengthen its leadership team. Brent Moore has joined the company as Chief Operating Officer, effective immediately, and Paul Anton recently joined as Chief Financial Officer.

Mr. Moore brings more than 20 years of operational leadership and manufacturing expertise to CAPTEK, most recently serving as Global CEO of Freemen Nutra Group LLC, where he led the company’s growth strategy and operational expansion across the nutraceutical sector. Prior to that, Mr. Moore was Executive Vice President of Operations at Merical, and earlier in his career, worked in various role including VP of Supply Chain and Procurement at Pharmavite.

Mr. Anton joined CAPTEK earlier this year from Calavo Growers. He brings extensive experience in financial leadership within the health and wellness industry, with a focus on building teams and systems to support sustainable expansion.

“We’re thrilled to welcome Brent and Paul to CAPTEK,” said Brett Buatti, Chief Executive Officer of CAPTEK. “Brent’s deep operational expertise and our successful collaboration over the years give me tremendous confidence in his ability to elevate our operations and deliver on our strategic priorities. Paul’s strong financial and strategic background has already made a positive impact, and together they round out a high-caliber leadership team that positions CAPTEK for continued growth and excellence.”

“I’m excited to reunite with Brett and join the talented team at CAPTEK,” said Mr. Moore. “The company has an impressive foundation and a clear vision for the future. I look forward to helping drive the next phase of operational excellence and supporting CAPTEK’s mission to be the most trusted partner in the softgel and gummy sectors.”

“Joining CAPTEK is an exciting opportunity to build on its strong foundation and help shape the next phase of growth,” said Mr. Anton. “It’s an honor to join such a talented team and I look forward to collaborating across the organization to ensure our financial strategy supports operational excellence and long-term success.”

About CAPTEK^® Softgel International, Inc.

CAPTEK Softgel International, Inc. (CSI) is a privately-owned, FDA registered and audited, GMP-certified, full-service contract manufacturer of custom dietary supplement formulations. CSI features high-efficiency encapsulation lines operating 24/5, capable of producing more than 10 billion soft gels annually. The company’s facilities encompass approximately 290,000 square feet of production, analytical laboratory, pilot laboratory, and warehousing space. CAPTEK fully complies with FDA cGMP standards and has been independently certified by NSF International. For more information, visit www.capteksoftgel.com.

About Swander Pace Capital

Swander Pace Capital (SPC) is a private equity firm that invests in companies that are integral to consumers’ lives. SPC’s consumer industry experience informs the firm’s strategic approach and seeks to add value through access to its SPC Playbook, senior team, and extensive network. The firm partners with management teams to help build companies to their full potential. SPC invests in businesses across two key domains of consumer lifestyles: Food and Beverage and Health and Wellness. With offices in California and New Jersey, SPC has invested in approximately 65 platform companies and raised cumulative equity commitments of approximately $2.2 billion since 1996. For more information, visit www.spcap.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251022984490/en/